{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:07:06Z","timestamp":1790089626359,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1331\/154434504322904569","type":"journal-article","created":{"date-parts":[[2004,3,16]],"date-time":"2004-03-16T22:46:49Z","timestamp":1079477209000},"page":"S5-S13","source":"Crossref","is-referenced-by-count":56,"special_numbering":"S1","title":["Atherothrombosis: Epidemiology, Pathophysiology, and Prevention"],"prefix":"10.1016","volume":"44","author":[{"given":"Mark A.","family":"Munger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1331\/154434504322904569_bb0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1358836X9800300310","article-title":"Atherothrombosis: mechanisms and clinical therapeutic approaches","volume":"3","author":"Fuster","year":"1998","journal-title":"Vasc Med."},{"issue":"suppl A","key":"10.1331\/154434504322904569_bb0015","first-page":"A27","article-title":"Unifying concepts of arterial vascular disease","volume":"1","author":"Nenci","year":"1999","journal-title":"Eur Heart J Suppl"},{"key":"10.1331\/154434504322904569_bb0020","series-title":"Update","author":"American Heart Association Heart Disease and Stroke Statistics","year":"2002"},{"key":"10.1331\/154434504322904569_bb0025","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jama.290.7.932","article-title":"Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence","volume":"290","author":"Anand","year":"2003","journal-title":"JAMA."},{"key":"10.1331\/154434504322904569_bb0030","first-page":"1355","article-title":"A definition of advanced type of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Atherosclerosis","volume":"92","author":"Stary","year":"1995","journal-title":"American Heart Association. Circulation."},{"key":"10.1331\/154434504322904569_bb0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904569_bb0040","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","article-title":"Mechanisms leading to myocardial infarction: insights from studies of vascular biology","volume":"90","author":"Fuster","year":"1994","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/0735-1097(96)00014-9","article-title":"Matching the intensity of risk factor management with the hazard for coronary disease events. Pathogenesis of coronary disease: the biology role of risk factors","volume":"27","author":"Fuster","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1331\/154434504322904569_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00001573-200211000-00007","article-title":"Biologic aspects of vulnerable plaque","volume":"17","author":"Corti","year":"2002","journal-title":"Curr Opin Cardiol."},{"key":"10.1331\/154434504322904569_bb0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(98)00107-5","article-title":"Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis","volume":"139","author":"Camejo","year":"1998","journal-title":"Atherosclerosis."},{"key":"10.1331\/154434504322904569_bb0060","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI114562","article-title":"Minimally modified low density lipoprotein stimulates monocyte endothelial interactions","volume":"85","author":"Berliner","year":"1990","journal-title":"J Clin Invest."},{"key":"10.1331\/154434504322904569_bb0065","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI115932","article-title":"Lysophosphatidyl-choline, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells","volume":"90","author":"Kume","year":"1992","journal-title":"J Clin Invest."},{"key":"10.1331\/154434504322904569_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.RES.73.2.335","article-title":"Transferable lipids in oxidized LDL stimulate PAI-1 and inhibit tPA release from endothelial cells","volume":"73","author":"Kugiyama","year":"1993","journal-title":"Circulation Res."},{"key":"10.1331\/154434504322904569_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.ATV.3.3.215","article-title":"Lipoprotein oxidation and lipoprotein-induced cardiotoxicity","volume":"3","author":"Hessler","year":"1983","journal-title":"Arteriosclerosis."},{"key":"10.1331\/154434504322904569_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.104.3.365","article-title":"Current concepts of the pathogenesis of the acute coronary syndromes","volume":"104","author":"Libby","year":"2001","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature."},{"key":"10.1331\/154434504322904569_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1253\/jcj.65.473","article-title":"Evolution and stabilization of vulnerable atherosclerotic plaques","volume":"65","author":"Libby","year":"2001","journal-title":"Jpn Circ J."},{"key":"10.1331\/154434504322904569_bb0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1126\/science.1990440","article-title":"Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis","volume":"251","author":"Cybulsky","year":"1991","journal-title":"Science."},{"key":"10.1331\/154434504322904569_bb0100","first-page":"665","article-title":"Expression of intercellular adhesion molecule-1 in atherosclerotic plaques","volume":"140","author":"Poston","year":"1992","journal-title":"Am J Pathol."},{"key":"10.1331\/154434504322904569_bb0105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokine\u2014chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904569_bb0110","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1073\/pnas.92.18.8264","article-title":"Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor and apolipoprotein E","volume":"92","author":"Smith","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1331\/154434504322904569_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904569_bb0120","first-page":"251","article-title":"Evidence for apoptosis in advanced human atheroma: co-localization with interleukin-1 beta-converting enzyme","volume":"147","author":"Geng","year":"1995","journal-title":"Am J Pathol."},{"key":"10.1331\/154434504322904569_bb0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.ATV.16.1.19","article-title":"Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1-beta","volume":"16","author":"Geng","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1331\/154434504322904569_bb0130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00041433-199510000-00013","article-title":"The extracellular matrix and atherosclerosis","volume":"6","author":"Wight","year":"1995","journal-title":"Curr Opin Lipidol."},{"key":"10.1331\/154434504322904569_bb0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.RES.77.5.863","article-title":"Matrix metalloproteinases and cardiovascular disease","volume":"77","author":"Dollery","year":"1995","journal-title":"Circ Res."},{"key":"10.1331\/154434504322904569_bb0140","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/01.CIR.92.8.2029","article-title":"A skeleton in the atherosclerosis closet","volume":"92","author":"Demer","year":"1995","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0145","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/01.CIR.100.4.e20","article-title":"Infection and atherosclerosis: emerging mechanistic paradigms","volume":"100","author":"Epstein","year":"1999","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/res.90.1.2","article-title":"The multiple mechanisms by which infection may contribute to atherosclerosis development and course","volume":"90","author":"Epstein","year":"2002","journal-title":"Circ Res."},{"key":"10.1331\/154434504322904569_bb0155","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0160","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.CIR.93.7.1354","article-title":"Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death","volume":"93","author":"Farb","year":"1996","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0165","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.282.21.2035","article-title":"Hemodynamic shear stress and its role in atherosclerosis","volume":"282","author":"Malek","year":"1999","journal-title":"JAMA."},{"key":"10.1331\/154434504322904569_bb0170","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/01.ATV.17.10.1859","article-title":"The unstable atheroma","volume":"17","author":"Lee","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1331\/154434504322904569_bb0175","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","article-title":"Stability and instability: the two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995","volume":"94","author":"Davies","year":"1996","journal-title":"Circulation"},{"issue":"suppl","key":"10.1331\/154434504322904569_bb0180","doi-asserted-by":"crossref","first-page":"17A","DOI":"10.1016\/S0002-9149(02)03146-6","article-title":"New understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging","volume":"9","author":"Corti","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1331\/154434504322904569_bb0185","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","article-title":"Thrombin and platelet activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest."},{"key":"10.1331\/154434504322904569_bb0190","first-page":"82","article-title":"The role of inflammation in plaque disruption and thrombosis","volume":"2","author":"Chyu","year":"2001","journal-title":"Rev Cardiovasc Med."},{"key":"10.1331\/154434504322904569_bb0195","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.7326\/0003-4819-129-12-199812150-00010","article-title":"Vulnerable plaque: pathobiology and clinical implications","volume":"129","author":"Kullo","year":"1998","journal-title":"Ann Intern Med."},{"key":"10.1331\/154434504322904569_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention trial results: I. Reduction in incidence of coronary heart disease","volume":"251","author":"Lipid Research Clinics Program","year":"1984","journal-title":"JAMA"},{"key":"10.1331\/154434504322904569_bb0205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904569_bb0210","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904569_bb0215","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA."},{"key":"10.1331\/154434504322904569_bb0220","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0225","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1331\/154434504322904569_bb0230","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.7326\/0003-4819-60-6-1103","article-title":"Cigarette smoking and coronary heart disease","volume":"60","author":"Kannel","year":"1964","journal-title":"Ann Intern Med."},{"key":"10.1331\/154434504322904569_bb0235","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.1988.03720070025028","article-title":"Cigarette smoking as a risk factor for stroke: the Framingham Study","volume":"259","author":"Wolf","year":"1988","journal-title":"JAMA."},{"key":"10.1331\/154434504322904569_bb0240","first-page":"13","article-title":"Cigarette smoking and peripheral arterial disease","volume":"12","author":"Kannel","year":"1986","journal-title":"Prim Cardiol."},{"key":"10.1331\/154434504322904569_bb0245","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198512123132404","article-title":"The risk of myocardial infarction after quitting smoking in men under 55 years of age","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904569_bb0250","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1331\/154434504322904569_bb0255","first-page":"S62","article-title":"The prevention or delay of type 2 diabetes","volume":"26","author":"Sherwin","year":"2003","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1331\/154434504322904569_bb0260","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2337\/diacare.26.2007.S25","article-title":"Implications of the diabetes control and complications trial","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care."},{"key":"10.1331\/154434504322904569_bb0265","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bmj.325.7367.762","article-title":"ABC of antithrombotic therapy. An overview of antithrombotic therapy","volume":"325","author":"Blann","year":"2002","journal-title":"BMJ"},{"key":"10.1331\/154434504322904569_bb0270","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJM198801283180431","article-title":"Preliminary report: findings from the aspirin component on the ongoing Physicians' Health Study","volume":"318","author":"Steering Committee of the Physicians' Health Study Research Group","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904569_bb0275","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"BMJ."},{"key":"10.1331\/154434504322904569_bb0280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis Prevention Trial: randomized trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","author":"Medical Research Council's General Practice Research Framework","year":"1998","journal-title":"Lancet"},{"key":"10.1331\/154434504322904569_bb0285","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet."},{"key":"10.1331\/154434504322904569_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice","volume":"357","author":"Collaborative Group of the Primary Prevention Project","year":"2001","journal-title":"Lancet"},{"key":"10.1331\/154434504322904569_bb0295","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","article-title":"Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"136","author":"Hayden","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1331\/154434504322904569_bb0300","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.1991.03470040085027","article-title":"A prospective study of aspirin use and primary prevention of cardiovascular disease in women","volume":"266","author":"Manson","year":"1991","journal-title":"JAMA."},{"key":"10.1331\/154434504322904569_bb0305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1331\/154434504322904569_bb0310","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1331\/154434504322904569_bb0315","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.103.3.363","article-title":"Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery","volume":"103","author":"Bhatt","year":"2001","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature."},{"key":"10.1331\/154434504322904569_bb0325","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0735-1097(00)00817-2","article-title":"Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy","volume":"36","author":"Moshfegh","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"10.1331\/154434504322904569_bb0330","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med."},{"key":"10.1331\/154434504322904569_bb0335","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effect of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet."},{"key":"10.1331\/154434504322904569_bb0340","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA."},{"key":"10.1331\/154434504322904569_bb0345","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/00004872-199715110-00014","article-title":"Enhanced expression of angiotensinconverting enzyme is associated with progression of coronary atherosclerosis in humans","volume":"15","author":"Ohishi","year":"1997","journal-title":"J Hypertens."},{"key":"10.1331\/154434504322904569_bb0350","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty","year":"2000","journal-title":"J Clin Invest."},{"issue":"suppl","key":"10.1331\/154434504322904569_bb0355","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00005344-200109011-00002","article-title":"Anti-ischemic effects of angiotensin-converting enzyme inhibitors: a future therapeutic perspective","volume":"37","author":"Ambrosioni","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1331\/154434504322904569_bb0360","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinte.163.10.1155","article-title":"Renin-angiotensin system and atherothrombotic disease: from genes to treatment","volume":"163","author":"Jacoby","year":"2003","journal-title":"Arch Intern Med."},{"key":"10.1331\/154434504322904569_bb0365","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1440-1681.1996.tb03038.x","article-title":"Angiotensin-converting enzyme inhibitors and atherosclerosis: relevance of animal models to human disease","volume":"23","author":"Fennesssy","year":"1996","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"10.1331\/154434504322904569_bb0370","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.103.7.919","article-title":"Effects of ramipril and vitamin E on atherosclerosis: the Study to Evaluate Carotid Ultrasound changes in patients treated with Ramipril and vitamin E (SECURE)","volume":"103","author":"Lonn","year":"2001","journal-title":"Circulation."},{"key":"10.1331\/154434504322904569_bb0375","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9149(98)00780-2","article-title":"Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet: Quinapril Ischemic Event Trial","volume":"83","author":"Cashin-Hemphill","year":"1999","journal-title":"Am J Cardiol."},{"key":"10.1331\/154434504322904569_bb0380","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"The Heart Outcome Prevention Evaluation Study Investigators","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1331\/154434504322904569_bb0385","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115318525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319115318525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:02:02Z","timestamp":1682654522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319115318525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S1544319115318525"],"URL":"https:\/\/doi.org\/10.1331\/154434504322904569","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}